健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者的效果

doi:10.3760/cma.j.cn441417-20250326-18012

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (18): 3053-3058.DOI: 10.3760/cma.j.cn441417-20250326-18012

健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者的效果

贾乐乐¹ 宋媛媛¹ 何敏敏² 黄雅慧¹

¹西安市中医医院，西安 710021；²西安市灞桥区狄寨社区卫生服务中心，西安 710038

收稿日期:2025-03-26 出版日期:2025-09-15 发布日期:2025-09-26
通讯作者: 何敏敏，Email：1096022827@qq.com
基金资助:
陕西省自然科学基础研究计划（2021JM-577）；国家中医药管理局2022年全国名老中医药专家传承工作室建设项目（国中医药人教函［2022］75号）

Jianpi Huoxue formula combined with acupuncture and moxibustion for patients with precancerous lesions of chronic atrophic gastritis

Jia Lele¹, Song Yuanyuan¹, He Minmin², Huang Yahui¹

¹Xi'an Hospital of Traditional Chinese Medicine, Xi'an 710021, China; ²Dizhai Community Health Service Center, Baqiao District, Xi'an 710038, China

Received:2025-03-26 Online:2025-09-15 Published:2025-09-26
Contact: He Minmin, Email: 1096022827@qq.com
Supported by:
Basic Research Plan of Natural Science in Shaanxi (2021JM-577); Construction Project in 2022 Supported by National Famous Traditional Chinese Medicine Expert Inheritance Studio of National Administration of Traditional Chinese Medicine (No.202275)

摘要/Abstract

摘要：

目的　探讨健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者的效果。方法　选取2023年12月至2024年12月西安市中医医院收治的80例慢性萎缩性胃炎癌前病变患者进行随机对照试验。采用随机数字表法将其分为对照组（西药治疗）和观察组（健脾活血方联合针灸治疗），各40例。对照组男22例，女18例，年龄（54.63±6.58）岁，病程（5.63±2.54）年。观察组男21例，女19例，年龄（55.10±7.52）岁，病程（5.60±2.65）年。比较两组中医症状积分、胃黏膜功能、Toll样受体4（Toll-like receptor 4，TLR4）炎症通路以及血清肿瘤标志物等指标水平。采用ｔ检验和χ²检验进行统计分析。结果　治疗后，观察组主要症状积分、次要症状积分、总积分分别为（4.01±0.12）分、（3.10±0.21）分、（7.11±1.23）分，均低于对照组的（5.10±0.66）分、（4.00±0.52）分、（9.10±2.01）分（t=10.276、10.149、5.340，均P<0.05）。观察组胃黏膜炎症、腺体萎缩、肠上皮化生、异型增生评分分别为（0.98±0.13）分、（0.35±0.03）分、（0.48±0.12）分、（0.35±0.06）分，均低于对照组的（1.91±0.31）分、（1.55±0.23）分、（1.34±0.24）分、（1.23±0.17）分（t=17.497、32.720、20.270、30.872，均P<0.05）。观察组TLR4、核转录因子KB（nuclear factor kappa B，NF-κB）、白细胞介素-6（interleukin-6，IL-6）、肿瘤坏死因子-α（tumor necrosis factor alpha，TNF-α）水平分别为（10.70±0.06）%、（620.90±10.44）ng/L、（30.78±3.90）ng/L、（25.11±2.52）ng/L，均低于对照组的（15.98±0.31）%、（730.00±10.15）ng/L、（44.31±5.48）ng/L、（35.97±3.31）ng/L（t=105.758、47.388、12.722、16.510，均P<0.05）。观察组癌胚抗原（carcinoembryonic antigen，CEA）、糖类抗原19-9（carbohydrate antigen 19-9，CA19-9）、糖类抗原72-4（carbohydrate antigen 72-4，CA72-4）、糖类抗原125（carbohydrate antigen 125，CA125）水平分别为（9.10±1.23）mg/L、（30.02±3.10）U/ml、（4.37±1.30）U/ml、（17.58±2.37）U/ml，均低于对照组的（13.11±2.14）mg/L、（42.01±4.17）U/ml、（6.38±2.34）U/ml、（25.35±3.41）U/ml（t=10.274、14.594、4.748、11.833，均P<0.05）。观察组不良反应总发生率低于对照组（χ²=5.164，P<0.05）。结论　健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者可有效改善患者胃黏膜功能，优化其TLR4炎症通路，降低不良反应发生风险。

关键词:

慢性萎缩性胃炎, 癌前病变, 健脾活血方, 针灸, TLR4炎症通路, 胃黏膜功能

Abstract:

Objective　To investigate the efficacy of Jianpi Huoxue formula combined with acupuncture and moxibustion for patients with precancerous lesions of chronic atrophic gastritis. Methods　Eighty patients with precancerous lesions of chronic atrophic gastritis treated at Xi'an Hospital of Traditional Chinese Medicine from December 2023 to December 2024 were selected for the randomized controlled trial. These patients were divided into a control group, treated with western medicine, and an observation group, treated with Jianpi Huoxue formula, acupuncture, and moxibustion, by the random number table method, with 40 cases in each group. There were 22 males and 18 females in the control group; they were (54.63±6.58) years old; their disease course was (5.63±2.54) years. There were 21 males and 19 females in the observation group; they were (55.10±7.52) years old; their disease course was (5.60±2.65) years. The scores of traditional Chinese medicine symptoms, gastric mucosal function, TLR4 inflammatory pathway, and serum tumor markers were compared between the two groups. ｔ and χ² tests were used for the statistical analysis. Results　After the treatment, the scores of major and minor symptoms and total score in the observation group were 4.01±0.12, 3.10±0.21, and 7.11±1.23, which were lower than those in the control group (5.10±0.66, 4.00±0.52, and 9.10±2.01) (t=10.276, 10.149, and 5.340; all P<0.05). The scores of gastric mucosal inflammation, glandular atrophy, intestinal metaplasia, and dysplasia in the observation group were 0.98±0.13, 0.35±0.03, 0.48±0.12, and 0.35±0.06, which were lower than those in the control group (1.91±0.31, 1.55±0.23, 1.34±0.24, and 1.23±0.17) (t=17.497, 32.720, 20.270, and 30.872; all P<0.05). The levels of Toll-like receptor 4 (TLR4), nuclear factor kappa B (NF-κB), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) in the observation group were (10.70±0.06)%, (620.90±10.44) ng/L, (30.78±3.90) ng/L, and (25.11±2.52) ng/L, which were lower than those in the control group [(15.98±0.31)%, (730.00±10.15) ng/L, (44.31±5.48) ng/L, and (35.97±3.31) ng/L] (t=105.758, 47.388, 12.722, and 16.510; all P<0.05). The levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 72-4 (CA72-4), and carbohydrate antigen 125 (CA125) in the observation group were (9.10±1.23) mg/L, (30.02±3.10) U/ml, (4.37±1.30) U/ml, and (17.58±2.37) U/ml, which were lower than those in the control group [(13.11±2.14) mg/L, (42.01±4.17) U/ml, (6.38±2.34) U/ml, and (25.35±3.41) U/ml] (t=10.274, 14.594, 4.748, and 11.833; all P<0.05). The overall incidence rate of adverse reactions in the observation group was lower than that in the control group (χ²=5.164; P<0.05). Conclusion　Jianpi Huoxue formula combined with acupuncture and moxibustion in the treatment of patients with precancerous lesions of chronic atrophic gastritis can effectively improve their gastric mucosal function, optimize the TLR4 inflammatory pathway, and reduce the risk of adverse reactions.

Key words:

Chronic atrophic gastritis, Precancerous lesions, Jianpi Huoxue , formula, Acupuncture and moxibustion, TLR4 inflammatory pathway, Gastric mucosal function

贾乐乐宋媛媛何敏敏黄雅慧.

健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者的效果 [J]. 国际医药卫生导报, 2025, 31(18): 3053-3058.

Jia Lele, Song Yuanyuan, He Minmin, Huang Yahui.

Jianpi Huoxue formula combined with acupuncture and moxibustion for patients with precancerous lesions of chronic atrophic gastritis [J]. International Medicine and Health Guidance News, 2025, 31(18): 3053-3058.

参考文献

[1] Yin Y, Liang H, Wei N, et al. Prevalence of chronic atrophic gastritis worldwide from 2010 to 2020: an updated systematic review and meta-analysis[J]. Ann Palliat Med, 2022,11(12):3697-3703. DOI: 10.21037/apm-21-1464.
[2] 江晓涛,李培武,杨泽虹,等. 刘凤斌对慢性萎缩性胃炎"炎-癌"转化的病机探索与辨治思路[J]. 广州中医药大学学报, 2024,41(7):1880-1885. DOI:10.13359/j.cnki.gzxbtcm.2024.07.033.
[3] Piazuelo MB, Bravo LE, Mera RM ,et al. The colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions[J].Gastroenterology, 2021, 160(4):1106-1117.e3. DOI:10.1053/j.gastro.2020.11.017.
[4] 杨天翼,宗湘裕. 活血化瘀、健脾疏肝法治疗慢性萎缩性胃炎胃络瘀阻证的临床研究[J]. 国际中医中药杂志,2023,45(5):558-562. DOI: 10.3760/cma.j.cn115398-20220304-00048.
[5] Liu Y, Huang T, Wang L, et al. Traditional Chinese medicine in the treatment of chronic atrophic gastritis, precancerous lesions and gastric cancer[J]. J Ethnopharmacol, 2025,337(Pt 1):118812. DOI: 10.1016/j.jep.2024.118812.
[6] 荣华,付永民,杜旭. 丹石健脾汤联合针灸治疗慢性萎缩性胃炎胃癌前病变43例[J]. 环球中医药,2023,16(4):765-768. DOI:10.3969/j.issn.1674-1749.2023.04.035.
[7] 中华中医药学会,«胃复春治疗萎缩性胃炎癌前病变临床应用专家共识»项目组. 胃复春治疗萎缩性胃炎癌前病变临床应用专家共识[J]. 中医杂志,2023,64(2):212-216. DOI:10.13288/j.11-2166/r.2023.02.019.
[8] 中华医学会消化病学分会. 中国慢性胃炎共识意见精简版(2017年,上海)[J]. 上海医学,2017,40(12):705-708.
[9] 罗慧,唐梅文,农复香,等. 中医药防治慢性萎缩性胃炎癌变作用机制研究进展[J]. 陕西中医,2023,44(2):267-270. DOI:10.3969/j.issn.1000-7369.2023.02.030.
[10] 王婷,王海燕,富文俊. 不同针灸疗法治疗慢性萎缩性胃炎效果的网状Meta分析[J]. 中国全科医学,2024,27(23):2913-2920,2930. DOI:10.12114/j.issn.1007-9572.2023.0660.
[11] 徐雨璇,严展鹏,徐婷婷,等.健脾益气方对慢性萎缩性胃炎脾虚证大鼠胃组织的影响[J].中国医药导报,2021,18(21):4-7,32,197-198. DOI:10.20047/j.issn1673-7210.2021. 21.002.
[12] 魏冬梅,张斌,王邦才,等. 基于TLR4炎症通路探讨养胃和络饮对慢性萎缩性胃炎大鼠的作用机制[J]. 中国药学杂志,2023,58(12):1102-1109. DOI:10.11669/cpj.2023.12.006.
[13] 李炳媚,王静,王思佳,等. 胃癌组织中HIPK2和MDR-1的表达及临床意义[J]. 国际医药卫生导报,2025,31(6):896-899. DOI:10.3760/cma.j.cn441417-20240101-06004.

[1]	马昀欣李金涛李仁心秀. 基于经筋理论的针灸疗法用于脑卒中后肢体痉挛患者的效果研究 [J]. 国际医药卫生导报, 2025, 31(7): 1079-1083.
[2]	曾庆房朱盼盼施海. miR-375、CCL20与CEA联检对Hp感染相关胃癌前病变的诊断价值 [J]. 国际医药卫生导报, 2025, 31(6): 890-895.
[3]	李希岭姜静孟文文王海涛. 低频脉冲电刺激结合温针灸治疗老年顽固性面瘫的临床疗效观察 [J]. 国际医药卫生导报, 2025, 31(17): 2921-2925.
[4]	张元戎班江文陈雯雯王少敏孙旭冉谭宝. 基于“通络导滞”探讨慢性萎缩性胃炎的辨证思路 [J]. 国际医药卫生导报, 2024, 30(4): 628-631.
[5]	吕运良万彩玲王付涛常立国. 针灸联合本体感觉神经肌肉促进技术对脑卒中后肢体功能障碍患者的疗效分析 [J]. 国际医药卫生导报, 2024, 30(3): 398-403.
[6]	魏小利张维周贾健苟平平于小蕾袁媛王清. 中医针灸联合Otago运动对脑卒中患者心理障碍和生活质量的影响 [J]. 国际医药卫生导报, 2024, 30(24): 4087-4091.
[7]	陆丽娜郭凯. 痉挛型脑瘫患儿采用针灸推拿结合黄芪桂枝五物汤治疗的效果 [J]. 国际医药卫生导报, 2024, 30(22): 3735-3739.
[8]	张聪伟吕小龙樊振杜晓泉万雪姣. 健脾消萎汤联合西药治疗慢性萎缩性胃炎伴癌前病变患者的效果 [J]. 国际医药卫生导报, 2024, 30(13): 2163-2168.
[9]	孙敦坡王益松. 温针灸联合丙酸氟替卡松鼻喷雾剂在变应性鼻炎中的应用 [J]. 国际医药卫生导报, 2024, 30(12): 2015-2020.
[10]	郭瑞歆高浩哲高香香. 瘀血痹片联合温针灸对肩周炎患者的疗效分析 [J]. 国际医药卫生导报, 2024, 30(12): 2021-2025.
[11]	李小霞强霞霞高香香. 三阴交温针灸联合运动疗法对脑卒中后抑郁患者的疗效 [J]. 国际医药卫生导报, 2024, 30(10): 1693-1697.
[12]	于丰源刘聪阮佳朋. 祛瘀生新针法联合康复疗法对脑梗死患者的疗效 [J]. 国际医药卫生导报, 2023, 29(7): 987-990.
[13]	李靓璐刘军娜石泽璇牛琼. 人工智能在早期胃癌诊断和治疗中的应用现状及未来展望 [J]. 国际医药卫生导报, 2023, 29(4): 445-448.
[14]	翁瑜君陈志宁梁伟海余永森林国伟唐梁刘晓俊. 智三针疗法对PSCI大鼠学习和记忆能力的影响 [J]. 国际医药卫生导报, 2023, 29(23): 3417-3421.
[15]	李胜利刘洋. 肩三针温针灸联合小针刀治疗肩周炎的临床效果观察 [J]. 国际医药卫生导报, 2023, 29(20): 2864-2868.

健脾活血方联合针灸治疗慢性萎缩性胃炎癌前病变患者的效果

Jianpi Huoxue formula combined with acupuncture and moxibustion for patients with precancerous lesions of chronic atrophic gastritis

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics